1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial

Autor: G. Gravis Mescam, X. Maldonado, G. Roubaud, R.S. McDermott, A. Flechon, B. Tombal, S. Supiot, D.R. Berthold, R. Philippe, G. Kacso, F. Calabrò, J.F. Berdah, A. Hasbini, M. Silva, A. Thiery-Vuillemin, A. Rodriguez-Vida, J.A. McCaffrey, H. Ribault, S. Foulon, K. Fizazi

Publikováno v: Annals of Oncology. 33:S1162-S1163

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::454074180768722b96bc89722f4ff096
https://doi.org/10.1016/j.annonc.2022.07.1493

Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.

Autor: Bossi A; Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France; Amethyst Group, Paris, France. Electronic address: bossial@hotmail.com., Foulon S; Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France; Oncostat U1018, Inserm, Labelled Ligue Contre le Cancer, Villejuif, France., Maldonado X; Department of Radiotherapy, Vall d'Hebron University Hospital, Barcelona, Spain., Sargos P; Amethyst Group, Paris, France; Department of Radiotherapy, Institut Bergonie, Bordeaux, France., MacDermott R; Cancer Trials Ireland, Dublin, Ireland; St Vincents University Hospital, Dublin, Ireland., Kelly P; Department of Radiotherapy, Cork University Hospital, Cork, Ireland., Fléchon A; Centre Léon Bérard, Lyon, France., Tombal B; Clinique Universitaire St Luc, Brussels, Belgium., Supiot S; Department of Radiotherapy, Institut de Cancérologie de l'Ouest René Gauducheau, Saint Herblain, France., Berthold D; Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Ronchin P; Centre Azuréen Cancérologie, Mougins, France., Kacso G; Amethyst Radiotherapy Center, Iuliu Hatieganu University of Medecine and Pharmacy, Cluj-Napoca, Romania., Salem N; Department of Radiotherapy, Institut Paoli-Calmettes Aix-Marseille, Marseille, France., Calabro F; San Camillo Forlanini Hospitals, Rome, Italy., Berdah JF; Clinique Sainte Marguerite, Hyères, France., Hasbini A; Clinique Pasteur, Brest, France., Silva M; Centre François Baclesse, Caen, France., Boustani J; Centre Georges-Francois Leclerc, Dijon, France., Ribault H; Unicancer, Paris, France., Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.

Publikováno v: Lancet (London, England) [Lancet] 2024 Nov 23; Vol. 404 (10467), pp. 2065-2076.